3RD FLOOR, ALTRINCHAM, CHESHIRE, X0
Reports Financial Results and Business Highlights for the Second Quarter of 2025
Shareholder votes
Centessa Pharmaceuticals Clears IND for ORX142, Plans Clinical Data Release
News
Reports Financial Results and Business Highlights for the First Quarter of 2025
Annual Report to Security Holders
Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
Material Contracts
Q2
Q1
FY 2024
Amended Quarterly Report
Q3
Q3 amended
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
S-1MEF
SEC Staff Correspondence